Yes, good article Bung. It emphasises the deterrence effect as well as the actual test results. Roadside testing will be a goer for the deterrence effect alone.
Now that Oraline has been selected for roadside testing in Latvia, I would like to see the SBN board get up to speed on this issue.
Surely, given Latvia, the following Q&A comment on their website must now be questioned:
"SBN believes that the development of a roadside testing device would require a significant investment. The device also needs to be tailored to meet the specific needs of each market. This is not something SBN is working on at the moment though it may look into it in the future".
SBN Price at posting:
0.8¢ Sentiment: LT Buy Disclosure: Held
